Pricing Log in Create free account

Evaxion A/S - Sponsored ADR (EVAX) vs Seres Therapeutics, Inc. (MCRB)

Evaxion A/S - Sponsored ADR and Seres Therapeutics, Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR is the larger, with a market value of $23.0M against $20.8M — 1.1× the size. Evaxion A/S - Sponsored ADR has the higher net margin (0.00% vs −2,209.6%) and the higher return on invested capital (−245.8% vs −1,267.8%). Across the 15 metrics below, Evaxion A/S - Sponsored ADR leads on 12 and Seres Therapeutics, Inc. on 3.

Valuation

Metric EVAX MCRB Biotechnology median
P/E n/m n/m 10.60
P/S 2.06 9.25 9.40
P/B 2.31 0.92 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.38 49.24 9.02
Earnings yield (32.88%) (253.88%) (32.88%)
Free cash flow yield (139.47%) (323.94%) (23.13%)

Profitability

Metric EVAX MCRB Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin 0.00% (3,656.89%) 0.00%
Net margin 0.00% (2,209.55%) 0.00%
Free cash flow margin 0.00% (2,997.74%) 0.00%
Return on equity (96.10%) (144.35%) (51.96%)
Return on assets (36.20%) (44.85%) (46.06%)
Return on invested capital (245.79%) (1,267.77%) 0.00%

Growth

Metric EVAX MCRB Biotechnology median
Revenue growth (TTM) — (98.33%) 6.76%
EPS growth (last fiscal year) 87.79% 0.00% 29.88%
Revenue growth, 5-year CAGR — (53.03%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVAX MCRB Biotechnology median
Debt to equity 0.71 0.00 0.00
Current ratio 5.06 1.65 4.97
Net debt to EBITDA 1.87 0.51 1.01

Dividend

Metric EVAX MCRB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EVAX MCRB Biotechnology median
Market cap 23.02m 20.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack